Other
Analgesic
0
Pipeline Programs↗
13
Active Trials↗
6
Companies Involved↗
Analgesic is an early-stage landscape with 0 programs across 6 companies. The most active players are Pfizer, Bayer, Cara Therapeutics, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
89
clinical trials
Completed54 · 61%
Terminated9 · 10%
Unknown status7 · 8%
Recruiting6 · 7%
Withdrawn6 · 7%
Active, not recruiting3 · 3%
Other4 · 4%
Clinical Trials
Trial Activity
89 trials
Outcomes for Anesthesiologist-Led Care of Analgesic Protocol in Anorectal Surgery
Recruiting·—·N/A·NCT06015165·216 enrolled
The Effects of Preemptive Multimodal Analgesic on Endodontic Pain Following Root Canal Therapy.
Recruiting·—·Phase 1·NCT07400471·280 enrolled
Anesthetics and Analgesics in Children
Recruiting·—·N/A·NCT03427736·460 enrolled
Opioid Analgesic Reduction Study
Active, not recruiting·RRutgers, The State University of New Jersey·Phase 3·NCT04452344·1,815 enrolled
Analgesic and Anti-inflamatory Effect of Vit. B
Not yet recruiting·—·N/A·NCT06857734·90 enrolled
EMLA Cream as Analgesic for Outpatient Gynecological Procedures
Enrolling by invitation·—·Phase 4·NCT05970354·400 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)